Invesco
NERV icon

Invesco’s Minerva Neurosciences NERV Stock Holding History

Invesco’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+39,689
New +$215K ﹤0.01% 3554
2017
Q1 		– Sell
-15,330
Closed -$1.44M – 3734
2016
Q4 		$1.44M Buy
+15,330
New +$1.56M ﹤0.01% 2808

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's NERV Position: Q2 2026 in Review

Invesco opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 39,689 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #3554 among its holdings. This is a return to the name: Invesco previously reported a position in NERV as recently as Q4 2016.

Invesco first reported a position in NERV in Q4 2016 and has held it in 2 quarters since. The position peaked at $1.44M in Q4 2016. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Invesco held 39,689 shares of Minerva Neurosciences worth $220K as of Q2 2026.
  • Minerva Neurosciences was a new Invesco position in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3554 holding.
  • Invesco first reported a position in Minerva Neurosciences in Q4 2016 and has held it in 2 quarters since.
  • Invesco's Minerva Neurosciences position peaked at $1.44M in Q4 2016.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.